Evidence map›Paper›PMID 26627193›Full record

ArticleJournal of cellular biochemistry2016

Anaplerotic Accumulation of Tricarboxylic Acid Cycle Intermediates as Well as Changes in Other Key Metabolites During Heterotopic Ossification.

Eleanor L Davis, Elizabeth A Salisbury, Elizabeth Olmsted-Davis, Alan R Davis

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cellular biochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Eleanor L DavisCenter for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, 77030.
Elizabeth A SalisburyCenter for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, 77030.
Elizabeth Olmsted-DavisCenter for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, 77030.
Alan R DavisCenter for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, 77030.
Baylor College of Medicine · US

Funding

Research Education and Career Horizons ProgramK12GM084897 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI SIFERS, RICHARD NORMAN, SLAUGHTER, GAYLE · 2008 to 2016
$8.3M
Neural Mechanisms in Heterotopic OssificationR01AR066556 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI DAVIS, ALAN ROBERT · 2014 to 2018
$1.7M
NIAMS NIH HHS R01 AR066556NIGMS NIH HHS K12 GM084897
6 · The paper itself

Abstract

Heterotopic ossification (HO) is the de novo formation of bone that occurs in soft tissue, through recruitment, expansion, and differentiation of multiple cells types including transient brown adipocytes, osteoblasts, chondrocytes, mast cells, and platelets to name a few. Much evidence is accumulating that suggests changes in metabolism may be required to accomplish this bone formation. Recent work using a mouse model of heterotopic bone formation reliant on delivery of adenovirus-transduced cells expressing low levels of BMP2 showed the immediate expansion of a unique brown adipocyte-like cell. These cells are undergoing robust uncoupled oxidative phosphorylation to a level such that oxygen in the microenvironment is dramatically lowered creating areas of hypoxia. It is unclear how these oxygen changes ultimately affect metabolism and bone formation. To identify the processes and changes occurring over the course of bone formation, HO was established in the mice, and tissues isolated at early and late times were subjected to a global metabolomic screen. Results show that there are significant changes in both glucose levels, as well as TCA cycle intermediates. Additionally, metabolites necessary for oxidation of stored lipids were also found to be significantly elevated. The complete results of this screen are presented here, and provide a unique picture of the metabolic changes occurring during heterotopic bone formation.

Indexed as

MetabolomeAdenoviridaeAnimalsBone Morphogenetic Protein 2Cell DifferentiationChondrocytesCitric Acid CycleDisease Models, AnimalFibroblastsGene ExpressionGenetic VectorsGlycolysisInjections, IntramuscularMiceMice, Inbred C57BLMuscle, SkeletalBmp2 protein, mouseBone Morphogenetic Protein 2BMP2METABOLOMICSTRANSIENT BROWN FATTRICARBOXYLIC ACID CYCLE

Identifiers

PMID26627193
PMCPMC4784167
OpenAlexW2271246031

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.